ARCHIVES

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

This article is from The Cancer Letter archive.

Vol. 36 No. 09 | March 12, 2010

Download PDF Visit The Full Archive

Related Articles

Scientists Defend NCI, Criticize Post Series As Inaccurate

November 20, 1981

Public Should Be Warned About Smokeless tobacco Risks, Panel Says

January 24, 1986

The Cancer Letter takes summer publication break, back Sept. 12.

August 8, 2003

RFP: Sole Source

May 12, 2000

Congressional Appropriations Committee Leaders Blast White Plans To Slash NIH FY 1987 Budget

February 20, 1987

Funding Opportunities.

March 22, 2002